ASCO GI Conference Coverage
(Medscape Medical News) Jan 26, 2017 - Most cases of colorectal cancer are preceded by adenomas. Data show that chemoprevention with selective cyclooxygenase-2 (COX-2) inhibitors, particularly celecoxib (Celebrex, GD Searle), can reduce the incidence of these lesions.
(4SC AG) Jan 24, 2017 - 4SC AG today announced that the study investigators presented the detailed scientific study analysis (abstract #252) from the multi-center, randomized, 170 patient Phase II study conducted by 4SC’s cooperation partner Yakult Honsha Co., Ltd. (Yakult Honsha) in Japan and South Korea at the 2017 Gastrointestinal...
There are no ASCO GI Conference Coverage OBR Green articles.